the aid library

Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children

World Health Organization (2013)

Requirements for Emergency use Authorization of COVID-19 Rapid Test Kits

Ministry of Health, Kenya (2020) C1

Bases do Diagnóstico Microscópico da Malária: Parte I: Guia do Aluno

Pan American Health Organisation PAHO (2020) C_WHO

Segunda Edição. Este manual (Parte I dos módulos de capacitação em Bases do diagnóstico microscópico da malária) ajudará os participantes durante seu treinamento em diagnóstico microscópico da malária humana. O manual foi concebido como base para um treinamento formal de quatro a cinco s ... more

Job aid: How to do the rapid test to detect G6PD deficiency

World Health Organization WHO (2018) C_WHO

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan (2012) CC

Revised National Tuberculosis Control Programme

Antigen-Tests auf SARS-CoV-2 zur professionellen Anwendung

Paul-Ehrlich-Institu PEI (2022) CC

25 März 2022

10 opportunities for your child

BZgA - Bundeszentrale für gesundheitliche Aufklärung (2016) C1

What you should know about the early screening examinations U1 to U9 in Germany available in german, english, turkish, russian & arabic on: https://www.bzga.de/infomaterialien/kinder-und-jugendgesundheit/10-chancen-für-ihr-kind-faltblatt/

Training Course on the Clinical Management of Multidrug-Resistant Tuberculosis

United States Agency for International Development (USAID) (2012)

For full course visit: https://drtbnetwork.org/training-course-MDR-TB This course has been designed to take three days. It is composed of lectures, in-class readings, exercises, case discussions, and quizzes, which together are intended to provide a diverse and compelling learning experience for pa ... more

National Framework for Joint HIV/TB Collaborative Activities

NACO, DOTS (2013)

Bases do Diagnóstico Microscópico da Malária Parte II: Guia do instrutor

Pan American Health Organisation PAHO (2020) C_WHO

O volume de capacitação em Bases do diagnóstico microscópico da malária é composto por dois módulos, que servem como uma estrutura para que os instrutores montem o curso. Ele fornece as informações mínimas necessárias para capacitar alunos em diagnóstico microscópico da malária pelo m� ... more

India: Dried Blood Spots (DBS) Sample collection for Early Infant Diagnosis (EID) by PCR

National AIDS Control Organization (NACO) (2015) C1

National Health Mission India: Guidelines for Free Diagnostics Service Initiative (Split 2/2)

National Health Mission (NHM), Ministry of Health & Family Welfare, Government of India (2011) C1

Diagnóstico de Vibrio cholerae y Salmonella spp. por PCR

Organización Mundial de la Salud OMS (2010) C_WHO

Hinweise zur Malaria-Diagnostik und zur Interpretation von Malaria-Befunden bei einer Person, bei der ein Verdacht auf eine Infektion mit einem Erreger VHF besteht

Robert-Koch-Institut RKI (2018) C1

Erreger virales hemorraghisches Fieber (hier: Ebola-, Krim-Kongo-, Lassa-, Marburgvirus) und sich noch nicht in einem STAKOB Behandlungszentrum befindet (Stand 30.5.2018) Wenn der Verdacht auf eine reiseassoziierte Infektion mit einem Erreger eines viral-hämorrhagischen Fiebers (VHF) bei einem fi ... more

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC

Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector ... al population-based interventions to reduce CVD risk factors in the entire population. Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs. Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management. Conclusion: The large burden of CVD in LMICs and the fact that persons with high CVD can be identified and managed along cost-effective interventions mean that health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level. more

Guidelines for laboratory and field testing of molluscicides for control of schistosomiasis

World Health Organization World Health Organization WHO (2019) C_WHO

This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis.

Os Primeiros Poucos X (PPX). Casos e protocolo de investigação de contatos para a infecção pelo novo coronavírus 2019 (2019-nCoV). Versão 1.1, 29 de janeiro de 2020

OPASOPS (2020) C_WHO

FIND COVID-19 Diagnostics Resource Centre
recommended

FIND (2020) CC

FIND is collating an overview of SARS-CoV-2 tests that are commercially available or in development for the diagnosis of COVID-19. We do not guarantee that this is a comprehensive list, since the information below has been submitted voluntarily by test suppliers and is not independently verified. Pl ... more

Xpert MTB/RIF implementation manual

World Health Organization WHO (2014) C_WHO

Technical and operational ‘how-to’: practical considerations